Carol J Braun

Title: Carol J Braun: Innovator in Pharmaceutical Composition

Introduction

Carol J Braun is a notable inventor based in Baltimore, MD (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of trichomoniasis. Her innovative approach has led to the development of a unique method and composition that addresses this prevalent infection.

Latest Patents

Carol J Braun holds a patent for a method and pharmaceutical composition for treating or preventing trichomoniasis. This patent involves administering a therapeutically effective amount of secnidazole or a pharmaceutically acceptable salt in a microgranule formulation. The formulation comprises a plurality of microgranules, which can be beneficial for subjects who may also have bacterial vaginosis, are HIV-positive, or are suffering from metronidazole-resistant or tinidazole-resistant trichomoniasis. Additionally, the method can be applied to sexual partners of individuals with trichomoniasis. The microgranule formulation can also be combined with other treatments such as paromomycin, tinidazole, metronidazole, or boric acid.

Career Highlights

Carol J Braun is associated with Evofem Biosciences, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating effective solutions for complex health issues.

Collaborations

Some of her notable coworkers include Helen S Pentikis and David Palling, who contribute to the collaborative environment at Evofem Biosciences, Inc.

Conclusion

Carol J Braun's innovative work in pharmaceutical compositions showcases her dedication to improving health outcomes for individuals affected by trichomoniasis. Her contributions are vital in the ongoing fight against this infection, highlighting the importance of research and innovation in the medical field.